athenahealth, Inc. (NASDAQ:ATHN) insider Daniel P. Haley sold 1,583 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $124.56, for a total value of $197,178.48. Following the completion of the sale, the insider now directly owns 13,408 shares of the company’s stock, valued at approximately $1,670,100.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

athenahealth, Inc. (NASDAQ:ATHN) traded down 1.51% during trading on Tuesday, hitting $123.51. 499,349 shares of the stock were exchanged. The firm has a 50-day moving average of $132.79 and a 200-day moving average of $129.75. athenahealth, Inc. has a 52 week low of $90.11 and a 52 week high of $158.66. The stock has a market capitalization of $4.93 billion, a price-to-earnings ratio of 156.74 and a beta of 1.76.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. During the same quarter in the previous year, the company posted $0.34 earnings per share. The business’s revenue was up 15.0% on a year-over-year basis. Equities research analysts anticipate that athenahealth, Inc. will post $1.91 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Insider Selling: athenahealth, Inc. (ATHN) Insider Sells 1,583 Shares of Stock” was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/03/insider-selling-athenahealth-inc-athn-insider-sells-1583-shares-of-stock.html.

A number of large investors have recently added to or reduced their stakes in the stock. Comerica Bank lifted its holdings in athenahealth by 0.6% during the 1st quarter. Comerica Bank now owns 2,487 shares of the health services provider’s stock worth $302,000 after purchasing an additional 14 shares during the last quarter. Advisor Group Inc. grew its holdings in athenahealth by 2.8% in the 2nd quarter. Advisor Group Inc. now owns 1,744 shares of the health services provider’s stock valued at $244,000 after buying an additional 47 shares in the last quarter. Seven Bridges Advisors LLC grew its holdings in athenahealth by 5.4% in the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after buying an additional 67 shares in the last quarter. Teacher Retirement System of Texas grew its holdings in athenahealth by 2.2% in the 2nd quarter. Teacher Retirement System of Texas now owns 3,156 shares of the health services provider’s stock valued at $444,000 after buying an additional 67 shares in the last quarter. Finally, State of Wisconsin Investment Board grew its holdings in athenahealth by 0.9% in the 2nd quarter. State of Wisconsin Investment Board now owns 7,868 shares of the health services provider’s stock valued at $1,106,000 after buying an additional 70 shares in the last quarter.

A number of research analysts have recently commented on ATHN shares. Piper Jaffray Companies reissued a “buy” rating and set a $152.00 price objective on shares of athenahealth in a report on Friday, July 14th. BidaskClub downgraded athenahealth from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Citigroup Inc. restated a “buy” rating and issued a $186.00 target price (up from $169.00) on shares of athenahealth in a report on Monday, July 24th. UBS AG restated a “positive” rating and issued a $175.00 target price (up from $157.00) on shares of athenahealth in a report on Monday, July 24th. Finally, First Analysis lowered athenahealth from an “equal weight” rating to an “underweight” rating and boosted their target price for the stock from $99.00 to $125.00 in a report on Monday, July 24th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and twelve have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $149.91.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.